Regenxbio Inc, Uniqure NV at Citi Biotech Conference Transcript
The future looks like peering into the crystal ball, so to speak. So we have with us pretty distinguished guests from REGENXBIO, the CEO, Ken Mills; from Ultragenyx on my right here, Sam Wadsworth, the SVP and CSO of Gene Therapy Research & Development; and from uniQure, Matt Kapusta, the CEO of the company. So welcome, all of you.
Questions & Answers
And maybe to kick it off, I think it will be great to get your high-level views on your thoughts about how to build a gene manufacturing commercial-scale organization. What is needed to make gene therapy manufacturing successful? What are the ingredients? So what are the dos and the don'ts, so to speak, or the rules of the road to get to successful products. So want to kick it off, Matt?
Sure. Yes. We do know a thing or 2 about that because we spent the last, 10, 15 years doing exactly that. And obviously, one of the things you need is a whole lot
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
